{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:24:54Z","timestamp":1717460694982},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"DOI":"10.7759\/cureus.61570","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:29:20Z","timestamp":1717414160000},"source":"Crossref","is-referenced-by-count":0,"title":["Mutations in Genes Producing Nitric Oxide and Hydrogen Sulfide and Their Connection With Apoptotic Genes in Chronic Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Bahaaddin A","family":"Saber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashabil","family":"Aygan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Salihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020148","article-title":"Sulfurtransferases and cystathionine beta-synthase expression in different human leukemia cell lines","volume":"12","author":"Jurkowska H","year":"2022","unstructured":"Jurkowska H, Wr\u00f3bel M, Jasek-Gajda E, Rydz L. Sulfurtransferases and cystathionine beta-synthase expression in different human leukemia cell lines. Biomolecules. 2022, 12:148. 10.3390\/biom12020148","journal-title":"Biomolecules"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2019.2019.0241","article-title":"WHO 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitors","volume":"37","author":"Haznedaro\u011flu \u0130C","year":"2020","unstructured":"Haznedaro\u011flu \u0130C, Kuzu I, \u0130lhan O. WHO 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitors. Turk J Haematol. 2020, 37:42-7. 10.4274\/tjh.galenos.2019.2019.0241","journal-title":"Turk J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-477687","article-title":"Measuring the symptom burden associated with the treatment of chronic myeloid leukemia","volume":"122","author":"Williams LA","year":"2013","unstructured":"Williams LA, Garcia Gonzalez AG, Ault P, et al.. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013, 122:641-7. 10.1182\/blood-2013-01-477687","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010215","article-title":"BCR-ABL1 tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid leukemia","volume":"14","author":"Amarante-Mendes GP","year":"2022","unstructured":"Amarante-Mendes GP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. BCR-ABL1 tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid leukemia. Pharmaceutics. 2022, 14:215. 10.3390\/pharmaceutics14010215","journal-title":"Pharmaceutics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bay062","article-title":"dbLGL: an online leukemia gene and literature database for the retrospective comparison of adult and childhood leukemia genetics with literature evidence","volume":"2018","author":"Liu Y","year":"2018","unstructured":"Liu Y, Luo M, Jin Z, Zhao M, Qu H. dbLGL: an online leukemia gene and literature database for the retrospective comparison of adult and childhood leukemia genetics with literature evidence. Database (Oxford). 2018, 2018:bay062. 10.1093\/database\/bay062","journal-title":"Database (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3205125","article-title":"Cystathionine \u03b2-synthase in physiology and cancer","volume":"2018","author":"Zhu H","year":"2018","unstructured":"Zhu H, Blake S, Chan KT, Pearson RB, Kang J. Cystathionine \u03b2-synthase in physiology and cancer. Biomed Res Int. 2018, 2018:3205125. 10.1155\/2018\/3205125","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12749","article-title":"Gasotransmitters in the tumor microenvironment: impacts on cancer chemotherapy (review)","volume":"26","author":"Salihi A","year":"2022","unstructured":"Salihi A, Al-Naqshabandi MA, Khudhur ZO, et al.. Gasotransmitters in the tumor microenvironment: impacts on cancer chemotherapy (review). Mol Med Rep. 2022, 26:233. 10.3892\/mmr.2022.12749","journal-title":"Mol Med Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt034","article-title":"The yin and yang of nitric oxide in cancer progression","volume":"34","author":"Burke AJ","year":"2013","unstructured":"Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis. 2013, 34:503-12. 10.1093\/carcin\/bgt034","journal-title":"Carcinogenesis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2018.7527","article-title":"Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism","volume":"30","author":"Somasundaram V","year":"2019","unstructured":"Somasundaram V, Basudhar D, Bharadwaj G, et al.. Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism. Antioxid Redox Signal. 2019, 30:1124-43. 10.1089\/ars.2018.7527","journal-title":"Antioxid Redox Signal"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071881","article-title":"Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer","volume":"12","author":"Wang H","year":"2020","unstructured":"Wang H, Wang L, Xie Z, Zhou S, Li Y, Zhou Y, Sun M. Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer. Cancers (Basel). 2020, 12:1881. 10.3390\/cancers12071881","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82244-x","article-title":"In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients","volume":"11","author":"Housein Z","year":"2021","unstructured":"Housein Z, Kareem TS, Salihi A. In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients. Sci Rep. 2021, 11:2536. 10.1038\/s41598-021-82244-x","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.592761","article-title":"Pan-cancer analysis of NOS3 identifies its expression and clinical relevance in gastric cancer","volume":"11","author":"Zou D","year":"2021","unstructured":"Zou D, Li Z, Lv F, et al.. Pan-cancer analysis of NOS3 identifies its expression and clinical relevance in gastric cancer. Front Oncol. 2021, 11:592761. 10.3389\/fonc.2021.592761","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.12.004","article-title":"Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases","volume":"21","author":"Aye le L","year":"2016","unstructured":"Aye le L, Loghavi S, Young KH, et al.. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases. Ann Diagn Pathol. 2016, 21:53-8. 10.1016\/j.anndiagpath.2015.12.004","journal-title":"Ann Diagn Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute myeloid leukemia in the real world: why population-based registries are needed","volume":"119","author":"Juliusson G","year":"2012","unstructured":"Juliusson G, Lazarevic V, Horstedt AS, et al.. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012, 119:3890-9. 10.1182\/blood-2011-12-379008","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09162-z","article-title":"Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study","volume":"22","author":"McLigeyo A","year":"2022","unstructured":"McLigeyo A, Rajab J, Oyiro P, et al.. Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study. BMC Cancer. 2022, 22:128. 10.1186\/s12885-021-09162-z","journal-title":"BMC Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_137_17","article-title":"Interleukin 6 and disease transformation in chronic myeloid leukemia: a northeast Indian population study","volume":"16","author":"Sharma K","year":"2020","unstructured":"Sharma K, Singh U, Rai M, Shukla J, Gupta V, Narayan G, Kumar S. Interleukin 6 and disease transformation in chronic myeloid leukemia: a northeast Indian population study. J Cancer Res Ther. 2020, 16:30-3. 10.4103\/jcrt.JCRT_137_17","journal-title":"J Cancer Res Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020220","article-title":"Hydrogen sulfide, an endogenous stimulator of mitochondrial function in cancer cells","volume":"10","author":"Szabo C","year":"2021","unstructured":"Szabo C. Hydrogen sulfide, an endogenous stimulator of mitochondrial function in cancer cells. Cells. 2021, 10:220. 10.3390\/cells10020220","journal-title":"Cells"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666201013154917","article-title":"A relationship between endothelial nitric oxide synthetase gene variants and substance use disorder","volume":"21","author":"Pehlivan S","year":"2021","unstructured":"Pehlivan S, Aydin PC, Nursal AF, Pehlivan M, Oyaci Y, Yazici AB. A relationship between endothelial nitric oxide synthetase gene variants and substance use disorder. Endocr Metab Immune Disord Drug Targets. 2021, 21:1679-84. 10.2174\/1871530320666201013154917","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2016.0149","article-title":"Clinical interpretation of genomic variations","volume":"33","author":"Sayito\u011flu M","year":"2016","unstructured":"Sayito\u011flu M. Clinical interpretation of genomic variations. Turk J Haematol. 2016, 33:172-9. 10.4274\/tjh.2016.0149","journal-title":"Turk J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S382090","article-title":"Chronic myeloid leukemia, from pathophysiology to treatment-free remission: a narrative literature review","volume":"14","author":"Rinaldi I","year":"2023","unstructured":"Rinaldi I, Winston K. Chronic myeloid leukemia, from pathophysiology to treatment-free remission: a narrative literature review. J Blood Med. 2023, 14:261-77. 10.2147\/JBM.S382090","journal-title":"J Blood Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v28i2.5","article-title":"Identification of prognostic and susceptibility markers in chronic myeloid leukemia using next generation sequencing","volume":"28","author":"Shokeen Y","year":"2018","unstructured":"Shokeen Y, Sharma NR, Vats A, et al.. Identification of prognostic and susceptibility markers in chronic myeloid leukemia using next generation sequencing. Ethiop J Health Sci. 2018, 28:135-46. 10.4314\/ejhs.v28i2.5","journal-title":"Ethiop J Health Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255262-mutations-in-genes-producing-nitric-oxide-and-hydrogen-sulfide-and-their-connection-with-apoptotic-genes-in-chronic-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:29:23Z","timestamp":1717414163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255262-mutations-in-genes-producing-nitric-oxide-and-hydrogen-sulfide-and-their-connection-with-apoptotic-genes-in-chronic-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.61570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}